RT Journal Article
SR Electronic
T1 Repression of Cell Proliferation and Androgen Receptor Activity in Prostate Cancer Cells by 2’-Hydroxyflavanone
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 4453
OP 4461
VO 33
IS 10
A1 MITSUO OFUDE
A1 ATSUSHI MIZOKAMI
A1 MISAKO KUMAKI
A1 KOUJI IZUMI
A1 HIROYUKI KONAKA
A1 YOSHIFUMI KADONO
A1 YASUHIDE KITAGAWA
A1 MINKYOUNG SHIN
A1 JIAN ZHANG
A1 EVAN T. KELLER
A1 MIKIO NAMIKI
YR 2013
UL http://ar.iiarjournals.org/content/33/10/4453.abstract
AB Background: Prevention of the development of castration-resistant from hormone-naïve prostate cancer is an important issue in maintaining the quality of life of the patients. We explored the effect of 2’-hydroxyflavanone on proliferation and androgen responsiveness using prostate cancer cell lines. Materials and Methods: To investigate the effect of 2’-hydroxyflavanone on proliferation, prostate cancer cells were treated with 2’-hydroxyflavanone. Androgen-responsiveness in LNCaP cells was confirmed by luciferase assay after transfection of luciferase reporter driven by prostate specific antigen promoter. To detect androgen receptor (AR) expression, reverse transcriptase polymerase chain reaction and western blot analysis were conducted. Results: 2’-Hydroxyflavanone inhibited the proliferation of PC-3 and DU145 cells by induction of apoptosis. 2’-Hydroxyflavanone inhibited the proliferation of LNCaP cells stimulated by androgens and attenuated androgen-responsiveness through down-regulation of AR protein. Conclusion: 2’-Hydroxyflavanone not only inhibited proliferation of prostate cancer cells, but also repressed androgen-responsiveness, suggesting that it might be a useful agent in preventing recurrence of prostate cancer.